Therapeutics: Chondroitin sulfate proteoglycans (CSPG); versican (VCAN)

Autoimmune disease

INDICATION: Multiple sclerosis (MS)

In vitro and mouse studies identified a UDP-N-acetylglucosamine-based inhibitor

Read the full 139 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE